These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30334582)

  • 41. An Expert Opinion on Advanced Insulin Pump Use in Youth with Type 1 Diabetes.
    Bode BW; Kaufman FR; Vint N
    Diabetes Technol Ther; 2017 Mar; 19(3):145-154. PubMed ID: 28135116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychology, technology, and diabetes management.
    Gonder-Frederick LA; Shepard JA; Grabman JH; Ritterband LM
    Am Psychol; 2016 Oct; 71(7):577-589. PubMed ID: 27690486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modern clinical management helps reducing the impact of type 1 diabetes in children.
    Scaramuzza AE; Zuccotti GV
    Pharmacol Res; 2015 Aug; 98():16-21. PubMed ID: 25779986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus.
    Papargyri P; Ojeda Rodríguez S; Corrales Hernández JJ; Mories Álvarez MT; Recio Córdova JM; Delgado Gómez M; Sánchez Marcos AI; Iglesias López RA; Herrero Ruiz A; Beaulieu Oriol M; Miralles García JM
    Endocrinol Nutr; 2014 Mar; 61(3):141-6. PubMed ID: 24355548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark.
    Roze S; de Portu S; Smith-Palmer J; Delbaere A; Valentine W; Ridderstråle M
    Diabetes Res Clin Pract; 2017 Jun; 128():6-14. PubMed ID: 28432898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deus ex machina: the use of technology in type 1 diabetes.
    Kerr D; Partridge H
    Prim Care Diabetes; 2011 Oct; 5(3):159-65. PubMed ID: 21727052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pascal's wager: combining continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Kerr D; Olateju T
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S43-50. PubMed ID: 20515306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes.
    Chamberlain JJ; Doyle-Delgado K; Peterson L; Skolnik N
    Ann Intern Med; 2019 Sep; 171(6):415-420. PubMed ID: 31404925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [CGM-Continuous Glucose Monitoring-Statement of the Austrian Diabetes Association (Update 2019)].
    Schütz-Fuhrmann I; Rami-Merhar B; Hofer SE; Fröhlich-Reiterer E; Mader J; Stadler M; Bischof M; Zlamal-Fortunat S; Laimer M; Weitgasser R
    Wien Klin Wochenschr; 2019 May; 131(Suppl 1):119-123. PubMed ID: 30980171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An analysis of data management tools for diabetes self-management: can smart phone technology keep up?
    Ciemins E; Coon P; Sorli C
    J Diabetes Sci Technol; 2010 Jul; 4(4):958-60. PubMed ID: 20663462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetes technologies - what the general physician needs to know.
    Li A; Hussain S
    Clin Med (Lond); 2020 Sep; 20(5):469-476. PubMed ID: 32934039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. USA Vs Europe: Who Is Leading the Diabetes Tech Race?
    Acosta GJ; Brown S; Zand AM; Kansara A; Sadhu A
    Curr Diab Rep; 2019 Nov; 19(11):128. PubMed ID: 31734741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Progress in therapy for and diagnosis of diabetes mellitus--application of blood glucose self monitoring].
    Takeda A
    Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):761-7. PubMed ID: 19472528
    [No Abstract]   [Full Text] [Related]  

  • 56. Perioperative glycaemic control.
    Preiser JC
    Anaesth Crit Care Pain Med; 2018 Jun; 37 Suppl 1():S3-S4. PubMed ID: 29679767
    [No Abstract]   [Full Text] [Related]  

  • 57. Management of diabetes in elderly patients during the COVID-19 pandemic: current and future perspectives.
    Rajpal A; Sayyed Kassem L; Aron DC
    Expert Rev Endocrinol Metab; 2021 Jul; 16(4):181-189. PubMed ID: 34096441
    [No Abstract]   [Full Text] [Related]  

  • 58. Diabetes update: some new thoughts about an old disease.
    Pohl SL; Clarke WL
    Occup Health Nurs; 1982 Dec; 30(12):15-8. PubMed ID: 6760012
    [No Abstract]   [Full Text] [Related]  

  • 59. Actionable self-monitoring of blood glucose: redefining the role for patients using multiple daily injection therapy.
    Kerr D; Messing R; Resch A
    J Diabetes Sci Technol; 2011 Nov; 5(6):1584-90. PubMed ID: 22226281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A tool for diabetes.
    Learner S
    Nurs Stand; 2009 Aug 5-11; 23(48):24-5. PubMed ID: 19753869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.